Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$2.05B |
| 2 |
Texas Instruments
TXN
|
+$1.69B |
| 3 |
NVIDIA
NVDA
|
+$1.36B |
| 4 |
Starbucks
SBUX
|
+$1.2B |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$949M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.77B |
| 2 |
Microsoft
MSFT
|
+$1.3B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.22B |
| 4 |
iShares US Real Estate ETF
IYR
|
+$1.11B |
| 5 |
Procter & Gamble
PG
|
+$915M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.33% |
| 2 | Consumer Discretionary | 7.25% |
| 3 | Financials | 7.18% |
| 4 | Communication Services | 6.16% |
| 5 | Healthcare | 5.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
Range Resources
RRC
$9.43B
| $2.65M | ﹤0.01% |
79,079
-196,103
| -71% | -$7.05M |
|
1902
NovaGold Resources
NG
$2.78B
| $2.65M | ﹤0.01% |
765,671
-264,989
| -26% | -$879K |
|
1903
Grand Canyon Education
LOPE
$3.93B
| $2.64M | ﹤0.01% |
18,893
-45,477
| -71% | -$6.27M |
|
1904
Atlantic Union Bankshares
AUB
$6.07B
| $2.64M | ﹤0.01% |
80,461
-32,768
| -29% | -$1.07M |
|
1905
SiTime
SITM
$17.5B
| $2.61M | ﹤0.01% |
21,018
+5,019
| +31% | +$535K |
|
1906
Aaon
AAON
$7.58B
| $2.61M | ﹤0.01% |
29,937
-39,197
| -57% | -$3.2M |
|
|
DEC
1907
Diversified Energy Company
DEC
$936M
| $2.61M | ﹤0.01% |
193,549
-177,757
| -48% | -$2.47M |
|
|
PCH
1908
DELISTED
PotlatchDeltic
PCH
| $2.6M | ﹤0.01% |
66,129
-73,031
| -52% | -$3.09M |
|
1909
Bruker
BRKR
$9.79B
| $2.6M | ﹤0.01% |
40,797
-56,672
| -58% | -$4.27M |
|
1910
ACI Worldwide
ACIW
$5.83B
| $2.6M | ﹤0.01% |
65,748
-60,030
| -48% | -$2.09M |
|
1911
Navient
NAVI
$830M
| $2.6M | ﹤0.01% |
178,676
-18,104
| -9% | -$280K |
|
1912
Community Bank
CBU
$3.5B
| $2.6M | ﹤0.01% |
55,093
-38,322
| -41% | -$1.73M |
|
1913
Immunovant
IMVT
$7.91B
| $2.6M | ﹤0.01% |
98,440
-110,830
| -53% | -$3.15M |
|
1914
Belden
BDC
$4.8B
| $2.6M | ﹤0.01% |
27,693
-48,081
| -63% | -$4.37M |
|
1915
Churchill Downs
CHDN
$5.82B
| $2.59M | ﹤0.01% |
18,578
-58,836
| -76% | -$7.73M |
|
1916
Ascendis Pharma A/S
ASND
$16B
| $2.59M | ﹤0.01% |
19,004
-2,068
| -10% | -$281K |
|
1917
Ultragenyx Pharmaceutical
RARE
$2.46B
| $2.59M | ﹤0.01% |
62,913
-55,860
| -47% | -$2.39M |
|
1918
CALL
Seagate
STX
$192B
| $2.58M | ﹤0.01% |
+25,000
| New | +$2.33M |
|
1919
Dycom Industries
DY
$12.5B
| $2.58M | ﹤0.01% |
15,282
-13,148
| -46% | -$2.05M |
|
1920
Agilysys
AGYS
$3.09B
| $2.57M | ﹤0.01% |
24,646
-10,269
| -29% | -$922K |
|
1921
Blue Owl Capital
OBDC
$5.56B
| $2.57M | ﹤0.01% |
167,090
+144,282
| +633% | +$2.31M |
|
1922
Kulicke & Soffa
KLIC
$4.91B
| $2.57M | ﹤0.01% |
52,175
+1,810
| +4% | +$85.1K |
|
1923
Geron
GERN
$860M
| $2.57M | ﹤0.01% |
604,981
+37,718
| +7% | +$147K |
|
|
LNW
1924
DELISTED
Light & Wonder
LNW
| $2.56M | ﹤0.01% |
24,366
-247,779
| -91% | -$23.7M |
|
1925
CALL
Unum
UNM
$14.3B
| $2.56M | ﹤0.01% |
+50,000
| New | +$2.59M |
|
Similar funds
Barclays's Q2 2024 Portfolio in Review
As of Q2 2024, Barclays held 5,455 positions worth $327B, up 14% from $288B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Barclays deployed $29.4B of net new capital in Q2 2024, opening 406 new positions and adding to 1,053 existing holdings. Its largest new stake was Ferrovial N.V. Ordinary Shares: 4,837,593 shares worth $186M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Apple, an estimated $2.77B trimmed.
- Barclays's largest Q2 2024 buy was Ferrovial N.V. Ordinary Shares: 4,837,593 shares worth $186M.
- Barclays added most to CRH in Q2 2024, an estimated $2.05B increase.
- Barclays's biggest Q2 2024 reduction was Apple, cutting an estimated $2.77B.
- Barclays fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $212M.
- Barclays's ten largest holdings make up 42% of its $327B portfolio in Q2 2024.
- Barclays opened 406 new positions and closed 646 in Q2 2024.
- Barclays's portfolio value rose 14% quarter-over-quarter to $327B.
Based on Barclays's 13F filing for Q2 2024, filed 14 Aug 2024.